Evidence-Based Benefits
- Acetylcholine enhancement — Huperzine A inhibits AChE more selectively than pharmaceutical alternatives, raising synaptic acetylcholine levels to support memory encoding and retrieval
- Memory improvement — a 1999 Chinese RCT (Xu et al., n=103) found 200mcg twice daily significantly improved memory in elderly patients with benign senescent forgetfulness
- Neuroprotection — Huperzine A blocks NMDA receptor-mediated excitotoxicity, protects against beta-amyloid toxicity, and reduces oxidative stress in neuronal tissue
- Student cognitive support — a Chinese trial in adolescent students found 100mcg twice daily improved memory quotient scores compared to placebo after 4 weeks
- Alzheimer's disease — a 2014 Cochrane-quality meta-analysis of Chinese trials found Huperzine A improved cognitive function and daily living activities in Alzheimer's patients